VNDA Financial Facts

Intangible asset amortization: 2.94M
Research and development: 7.29M
See Full Income Statement

Accumulated deficit: -345.26M
Intangible asset, net: 29.92M
See Full Balance Sheet

Vanda Pharma (VNDA) Earnings

  |   Expand Research on VNDA
Next EPS Date 7/28/22 *Est. EPS Growth Rate -26.7% *Last Qtr.
Average EPS % Beat Rate +314.7% Revenue Growth Rate -3.9% *Last Qtr.
Average % Move 1-Wk after EPS -12.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/5/22 Q122 $0.11-$0.01 +$0.12$60.2M$58M = Details
2/23/22 Q421 $0.12$0.08 +$0.04$68M$70.04M = Details
11/3/21 Q321 $0.14$0.16 -$0.02$70.1M$75M N/A Details
7/28/21 Q221 $0.17$0.14 +$0.03$67.9M$69.75M N/A Details
5/5/21 Q121 $0.15$0.15 $0.00$62.67M$68.5M N/A Details
2/10/21 Q420 $0.15$0.14 +$0.01$67.65M$64M N/A Details
10/28/20 Q320 $0.11$0.09 +$0.02$60.31M$63.95M = Details
8/5/20 Q220 $0.16$0.04 +$0.12$62.21M$61.95M = Details